Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor

Haemophilia

Volumn 11, Issue 1, 2005, Pages 2-4

  Laguna, Pawel ^a   Klukowska, A ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Dental extraction; Factor VIII inhibitor; Haemophilia A; Recombinant factor VIIa; rFVIIa

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 INHIBITOR; FIBRIN GLUE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADOLESCENT; ANEMIA; CHILD; CHILDHOOD DISEASE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; HEMOPHILIA A; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; ORAL BLEEDING; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TOOTH ERUPTION; TOOTH EXTRACTION;

BLOOD COAGULATION FACTOR INHIBITORS; CHILD; FACTOR VII; HEMOPHILIA A; HEMOSTASIS, SURGICAL; HUMANS; MALE; ORAL HEMORRHAGE; RECOMBINANT PROTEINS; TOOTH EXTRACTION;

EID: 13844281224     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01051.x     Document Type: Review

References (15)

1. Jańczuk Z, Banach J. Health problems of the stomatognathic system in the Polish population covered by stomatological health care place of residence and work. Czas Stomat 1990; 43: 1-6.
2. Szpringer-Nodzak M, Tawczyńska A, Moszczeńska-Cieślikowska B. Masticatory organ condition evaluation in children with blood coagulation defects. Czas Stomat 1992; XLV 3: 127-32.
3. Klukowska A, Zieleniewska B. The results of bleedings treatment in haemophilia A children with factor VIII inhibitor. Acta Haematol Pol 1994; 25: 349-54.
4. Ingerslev J, Freidman D, Gastineau D. Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa. Haemostasis 1996; 26: 118-23.
5. Knet G. The use of Novoseven for profuse bleedings in surgical patients. Abstract presented at the 6th Novo Nordisk Symposium on Treatment of Bleeding and Thrombotic Disorders. Copenhagen, Denmark, May 3-4, 2001.
6. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78: 1463-7.
7. Gastinean DA, Pruthi RK, Moir CR, Bolander B, Kgilchrist GS. The May Clinic surgical experience with congenital hemophilia and high titer inhibitors. Thromb Haemost 1997; 1(Suppl. 51).
8. Lusher IM. Recombinant factor VIIa (Novoseven) in the treatment of internal bleeding in patients with factor VII and IX inhibitors. Haemostasis 1996; 26 (Suppl. 1): 124-30.
9. Trangeborn L, Kjellman B, Elfstrand PO, Bagenholm T. Recombinant factor VIIa in an infant with hemophilia a and inhibitors. Acta Paediatr 1992; 81: 566-7.
10. O'Connell N, Mc Mahon C, Smith J et al. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors. Br J Haematol 2002; 116: 632-5.
11. Klukowska A, Laguna P, Obitko-Pludowska A, Rokicka-Milewska R. Use of activated recombinant factor VII (rFVIIa) in the treatment of hemofilia A children with high-titer inhibitor. Acta Haemat Pol 1998; 29: 401-6.
12. Hedner U, Glazer S, Pingel K et al. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet 1988; 2: 1193.
13. Rao L, Rapaport SI. Cells and the activation of factor VII. Haemostasis 1996; 26 (Suppl. 1): 1-5.
14. Rokicka-Milewska R, Krajewska-Martel A, Dyszy-Laube B. Epsilon-aminocaproic Acid for oral mucosal bleeding in hemophiliacs. Pol Arch Med Wewn 1966; 37: 445-50.
15. Dyszy-Laube B, Jastrzebski S, Szumilewicz-Serocka B, Kamińska D. Teeth extraction in haemophilic children. Czas Stom 1975; 28: 715-23.